Senling Feng

Third Affiliated Hospital of Guangzhou Medical University — China

Medicine · Health Sciences

17h-index813citations33works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(5), Drug Transport and Resistance Mechanisms(5), Ferroptosis and cancer prognosis(5), Pharmacological Effects of Natural Compounds(5), Bioactive Compounds in Plants(5)

Publications33 total

Research Progress on the Biological Activities and Clinical Applications of Pseudoprotodioscin
Current Issues in Molecular Biology·2025Open Access
Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a disproportionality analysis from the FAERS database
BMC Gastroenterology·2025Open Access
An integrin-based quercetin 7-rhamnoside liver-targeted delivery liposomes for intrahepatic cholestasis in pregnancy
Materials Today Bio·2025· 1 citedOpen Access
Elucidation of the mechanism Underlying the promotion of ferroptosis and enhanced antitumor immunity by citrus polymethoxyflavones in CRC cells
Frontiers in Pharmacology·2025· 6 citedOpen Access
A Progesterone Microneedle Patch for Self-Administration in the Prevention of Preterm Birth in a Mouse Model
Drug Design Development and Therapy·2025· 1 citedOpen Access
Fisetin exerts neuroprotective effects in vivo and in vitro by inhibiting ferroptosis and oxidative stress after traumatic brain injury
Frontiers in Pharmacology·2024· 22 citedOpen Access
Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a real-world analysis from FAERS database
2024Open Access
The superiority of PMFs on reversing drug resistance of colon cancer and the effect on aerobic glycolysis-ROS-autophagy signaling axis
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics·2024· 2 citedOpen Access
Isoquercitrin attenuates the progression of non-alcoholic steatohepatitis in mice by modulating galectin-3-mediated insulin resistance and lipid metabolism
Phytomedicine·2023· 19 cited
Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6/Nrf2/GPX4 signaling pathway
European Journal of Pharmacology·2023· 40 cited
Quercetin 7-rhamnoside protects against alpha-naphthylisothiocyanate (ANIT)-induced in cholestatic hepatitis rats by improving biliary excretion and inhibiting inflammatory responses
Frontiers in Pharmacology·2023· 9 citedOpen Access
Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer
Frontiers in Oncology·2022· 14 citedOpen Access
Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Pharmacological Research·2022· 30 cited
The combination of Lonicerae Japonicae Flos and Forsythiae Fructus herb-pair alleviated inflammation in liver fibrosis
Frontiers in Pharmacology·2022· 17 citedOpen Access
Nobiletin Induces Ferroptosis in Human Skin Melanoma Cells Through the GSK3β-Mediated Keap1/Nrf2/HO-1 Signalling Pathway
Frontiers in Genetics·2022· 47 citedOpen Access
Evaluation of lipid metabolism imbalance in HIV-infected patients with metabolic disorders using high-performance liquid chromatography-tandem mass spectrometry
Clinica Chimica Acta·2021· 5 citedOpen Access
Development of a novel ssDNA aptamer targeting cardiac troponin I and its clinical applications
Analytical and Bioanalytical Chemistry·2021· 17 cited
Wutou decoction ameliorates experimental rheumatoid arthritis via regulating NF-kB and Nrf2: Integrating efficacy-oriented compatibility of traditional Chinese medicine
Phytomedicine·2021· 80 cited
Hplc-Ms/Ms Analysis of Key Components of the Amino Acid Metabolism in the Serum of Acute Myocardial Infarction Patients
SSRN Electronic Journal·2021Open Access
Effects of cyclocarya paliurus flavonoid extract in non-alcoholic steatohepatitis mice: Intermeshing network pharmacology and in vivo pharmacological evaluation
Pharmacognosy Magazine·2021· 2 cited
page 1 of 2Next →

Frequent Co-authors

Zhongwen Yuan(23), Ying Xie(14), Wenting Zhu(9), Hongliu Jin(7), Wenzhe Ma(6), Liang Liu(6), Hua Zhou(4), Zhongqiu Liu(4), Yingying Duan(4), Yazhuo Li(3), Wanjun Lin(3), Jiajun Huang(3), Hongliang Huang(3), Pengke Yan(3), Xiao‐Ying Feng(3), Xiaojun Yao(2), Chu-Tian Mai(2), De-Chong Zheng(2), Changxiao Liu(2), Biao Qu(2)